ESP vs ESP With PECS

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

August 31, 2018

Study Completion Date

September 30, 2018

Conditions
Postoperative PainMitral Valve Disease
Interventions
PROCEDURE

Erector Spinae Plane blockade

Before the beginning of the procedure, ESP blockade will be performed under ultrasound control. A single-shot technique will be used with 0.375 % solution of ropivacaine: 0.1 mL per patients' KG. The maximum dose is 20 mL.

PROCEDURE

Pectoral Fascia block

Before the beginning of the procedure, PECS type I and II blocks will be performed under ultrasound control. A single-shot technique will be used with 0.375 % solution of ropivacaine: 0.1 mL per patients' KG. The maximum dose is 20 mL.

DRUG

Oxycodone

Each patient, before the end of surgery, will be administered i.v. 0.1 mg of oxycodone. PCA with oxycodone (1mg/mL) will be utilized during the postoperative period: 5-minute interval.

PROCEDURE

general anesthesia

Each patient will generally anesthetized and endotracheal tube will be inserted

DRUG

paracetamol

Paracetamol will be given i.v. every 6 hours.

Trial Locations (1)

35-501

Division of Cardiovascular Surgery, St. Jadwiga Provincial Clinical Hospital, Rzeszów, Poland, Rzeszów

All Listed Sponsors
collaborator

Division of Cardiovascular Surgery, St. Jadwiga Provincial Clinical Hospital, Rzeszów, Poland

UNKNOWN

lead

Medical University of Lublin

OTHER

NCT03592485 - ESP vs ESP With PECS | Biotech Hunter | Biotech Hunter